Islet Transplantation in Type I Diabetes With LEA29Y (Belatacept) Maintenance Therapy (CIT-04)
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2015
At a glance
- Drugs Belatacept (Primary) ; Basiliximab; Daclizumab; Mycophenolate mofetil
- Indications Islet cell transplant rejection
- Focus Therapeutic Use
- Acronyms LEEP
- 07 Jun 2017 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.